Targeting NF-kappaB-inducing kinase shapes B-cell homeostasis in myasthenia gravis
Abstract Background B cell immune dysregulation plays a critical role in myasthenia gravis (MG). However, targeted B-cell therapy such as rituximab may result in long-term peripheral B cell clearance and allow for the survival of plasma cells, contributing to frequent infections and relapses. Theref...
Saved in:
Main Authors: | Xiaoyu Huang, Zhouao Zhang, Zhouyi Wang, Tiancheng Luo, Mingjin Yang, Xinyan Guo, Xue Du, Tianyu Ma, Yong Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Journal of Neuroinflammation |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12974-025-03342-5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multiple Brain Abscesses in a Patient with Myasthenia Gravis – a Case Report
by: S. Radzevičiūtė, et al.
Published: (2023-12-01) -
The Association Between Myasthenia Gravis and Higher Extrathymic Cancer Risk
by: Mohamed Khateb, et al.
Published: (2025-01-01) -
Autoantibodies in myasthenia gravis: cluster analysis and clinical correlations
by: Xupeng Sun, et al.
Published: (2025-02-01) -
Thymus Hyperplasia and Thymoma Type B in Patients with Myasthenia Gravis: Two case reports and Literature Review
by: Selman Dumani, et al.
Published: (2025-01-01) -
Co-occurrence of Myasthenia Gravis and Multiple Sclerosis: A Case Report
by: G. Rynkevič, et al.
Published: (2024-02-01)